Live Breaking News & Updates on Mirvetuximab Soravtansine|Page 5

Stay updated with breaking news from Mirvetuximab soravtansine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ImmunoGen Stock: Takeda Swoops For Slice Of Elahere (NASDAQ:IMGN)

ImmunoGen Stock: Takeda Swoops For Slice Of Elahere (NASDAQ:IMGN)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Mark Enyedy , Mirvetuximab Soravtansine , Satoshi Uchida , Pivekimab Sunirine , Pharma Eisai , Pharma Roche , Immunogen Inc , Bald Eagle , Flight With , Seeking Alpha , Overall Survival , Objective Response Rate , Japanese Pharma , Oncology Satoshi Uchida , May Catch Up With , Evaluate Pharma , Bristol Myers Squibb , Japanese Pharma Eisai , Does It Justify Immunogen , Upwardly Mobile , Can Immunogen ,

FY2023 EPS Estimates for ImmunoGen, Inc. Boosted by Analyst (NASDAQ:IMGN)

FY2023 EPS Estimates for ImmunoGen, Inc. Boosted by Analyst (NASDAQ:IMGN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stacy Ann Coen , Mirvetuximab Soravtansine , Markj Enyedy , Analysts At Zacks Research , Partners Investment Advisory , Canaccord Genuity Group , Zacks Research , Immunogen Inc , Tower Group , Securities Exchange Commission , Topco Ltd , Free Report , Get Free Report , Genuity Group , Street Partners Investment Advisory , Montreal Can , Ann Coen , Exchange Commission , Immunogen Daily ,

ImmunoGen, Inc. (NASDAQ:IMGN) Receives $21.13 Consensus Target Price from Analysts

Shares of ImmunoGen, Inc. (NASDAQ:IMGN – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year […] ....

United States , Markj Enyedy , Stacy Ann Coen , Mirvetuximab Soravtansine , Canaccord Genuity Group , Immunogen Company Profile , Immunogen Inc , Partners Investment Advisory , Mackenzie Financial Corp , Xponance Inc , Get Free Report , Genuity Group , Truist Financial , Ann Coen , Financial Corp , Street Partners Investment Advisory , Arizona State Retirement System , State Retirement System , Get Free , Immunogen Daily , Nasdaq Imgn ,

ImmunoGen (NASDAQ:IMGN) Shares Up 4.7%

ImmunoGen, Inc. (NASDAQ:IMGN – Get Free Report)’s stock price shot up 4.7% during trading on Monday . The stock traded as high as $15.06 and last traded at $15.05. 2,793,916 shares traded hands during mid-day trading, a decline of 50% from the average session volume of 5,579,037 shares. The stock had previously closed at $14.37. […] ....

Markj Enyedy , Piper Sandler , Stacy Ann Coen , Mirvetuximab Soravtansine , Blair William Co , Blackrock Inc , Securities Exchange Commission , Metlife Investment Management , Immunogen Company Profile , York Mellon Corp , Immunogen Inc , Raymond James Financial Services Advisors Inc , Get Free Report , Ann Coen , Exchange Commission , James Financial Services Advisors , New York Mellon Corp , Life Investment Management , Blair William , Immunogen Daily , Nasdaq Imgn ,

Perkins Capital Management Inc. Acquires 9,000 Shares of ImmunoGen, Inc. (NASDAQ:IMGN)

Perkins Capital Management Inc. grew its holdings in shares of ImmunoGen, Inc. (NASDAQ:IMGN – Free Report) by 72.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,500 shares of the biotechnology company’s stock after purchasing an additional 9,000 shares during […] ....

Piper Sandler , Markj Enyedy , Stacy Ann Coen , Mirvetuximab Soravtansine , Perkins Capital Management Inc , Leo Brokerage , Jump Financial , Securities Exchange Commission , Immunogen Inc , Mirae Asset Global Investments Co , Canaccord Genuity Group , Barclays Plc , Fisher Asset Management , Perkins Capital Management , Free Report , Capital Management , Asset Global Investments , Asset Management , Genuity Group , Get Free Report , Ann Coen , Exchange Commission , Immunogen Daily , Nasdaq Imgn , Sec Filings , Hedge Fund Holdings ,